| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6761925
[patent_doc_number] => 20030125287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Antisense oligonucleotides and methods to induce tumor cell death'
[patent_app_type] => new
[patent_app_number] => 10/253132
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14695
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125287.pdf
[firstpage_image] =>[orig_patent_app_number] => 10253132
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/253132 | Antisense oligonucleotides and methods to induce tumor cell death | Sep 23, 2002 | Abandoned |
Array
(
[id] => 490445
[patent_doc_number] => 07214766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Peptides with enhanced stability to protease degradation'
[patent_app_type] => utility
[patent_app_number] => 10/252773
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10163
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214766.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252773 | Peptides with enhanced stability to protease degradation | Sep 22, 2002 | Issued |
Array
(
[id] => 6647080
[patent_doc_number] => 20030104440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Production and use of normalized DNA libraries'
[patent_app_type] => new
[patent_app_number] => 10/235181
[patent_app_country] => US
[patent_app_date] => 2002-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6861
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10235181
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/235181 | Production and use of normalized DNA libraries | Sep 2, 2002 | Abandoned |
| 10/111336 | Antisense modulation of y-box binding protein 1 expression | Aug 26, 2002 | Abandoned |
| 10/111334 | Antisense modulation of integrin-linked kinase expression | Aug 21, 2002 | Abandoned |
Array
(
[id] => 7400072
[patent_doc_number] => 20040023385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Antisense modulation of requiem expression'
[patent_app_type] => new
[patent_app_number] => 10/212993
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30060
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023385.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212993
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212993 | Antisense modulation of requiem expression | Aug 4, 2002 | Abandoned |
Array
(
[id] => 7400058
[patent_doc_number] => 20040023383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Antisense modulation of resistin expression'
[patent_app_type] => new
[patent_app_number] => 10/210833
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31328
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023383.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210833
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210833 | Antisense modulation of resistin expression | Jul 30, 2002 | Abandoned |
Array
(
[id] => 7400065
[patent_doc_number] => 20040023384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Antisense modulation of G protein-coupled receptor 12 expression'
[patent_app_type] => new
[patent_app_number] => 10/211908
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30832
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023384.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211908 | Antisense modulation of G protein-coupled receptor 12 expression | Jul 30, 2002 | Abandoned |
Array
(
[id] => 1005589
[patent_doc_number] => 06906186
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-14
[patent_title] => 'Antisense modulation of polo-like kinase expression'
[patent_app_type] => utility
[patent_app_number] => 10/209405
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30304
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/906/06906186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209405 | Antisense modulation of polo-like kinase expression | Jul 29, 2002 | Issued |
| 10/201605 | Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same | Jul 23, 2002 | Abandoned |
| 10/031474 | Antisense modulation of jun n-terminal kinase kinase-1 expression | Jul 22, 2002 | Abandoned |
Array
(
[id] => 7263888
[patent_doc_number] => 20040241844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Antisense modulation of c-reactive protein expression'
[patent_app_type] => new
[patent_app_number] => 10/483424
[patent_app_country] => US
[patent_app_date] => 2004-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25640
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483424 | Antisense modulation of c-reactive protein expression | Jul 14, 2002 | Issued |
Array
(
[id] => 6870606
[patent_doc_number] => 20030083296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Antisense modulation of caspase 8 expression'
[patent_app_type] => new
[patent_app_number] => 10/181177
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24708
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181177 | Antisense modulation of caspase 8 expression | Jul 11, 2002 | Abandoned |
Array
(
[id] => 6870605
[patent_doc_number] => 20030083295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Antisense modulation of caspase 3 expression'
[patent_app_type] => new
[patent_app_number] => 10/181107
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24568
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181107 | Antisense modulation of caspase 3 expression | Jul 10, 2002 | Abandoned |
Array
(
[id] => 6847696
[patent_doc_number] => 20030166863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Macrophage migration inhibitory factor-3'
[patent_app_type] => new
[patent_app_number] => 10/178731
[patent_app_country] => US
[patent_app_date] => 2002-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10099
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178731 | Macrophage migration inhibitory factor-3 | Jun 24, 2002 | Abandoned |
Array
(
[id] => 6843627
[patent_doc_number] => 20030148974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Antisense modulation of akt-3 expression'
[patent_app_type] => new
[patent_app_number] => 10/168771
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22751
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168771 | Antisense modulation of akt-3 expression | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6792092
[patent_doc_number] => 20030087436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Process for the production of biologically active polymeric nanoparticle-nucleic acid conjugates'
[patent_app_type] => new
[patent_app_number] => 10/174617
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3325
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174617 | Process for the production of biologically active polymeric nanoparticle-nucleic acid conjugates | Jun 18, 2002 | Abandoned |
Array
(
[id] => 6805381
[patent_doc_number] => 20030232775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Antisense modulation of phosphatidylinositol-4-phosphate 5-kinase, type II beta expression'
[patent_app_type] => new
[patent_app_number] => 10/175627
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30148
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232775.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175627 | Antisense modulation of phosphatidylinositol-4-phosphate 5-kinase, type II beta expression | Jun 17, 2002 | Abandoned |
Array
(
[id] => 6805376
[patent_doc_number] => 20030232770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Antisense modulation of hypothetical tumor endothelial marker expression'
[patent_app_type] => new
[patent_app_number] => 10/174020
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30197
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232770.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174020 | Antisense modulation of hypothetical tumor endothelial marker expression | Jun 16, 2002 | Abandoned |
Array
(
[id] => 6804640
[patent_doc_number] => 20030232034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Antisense modulation of junctional adhesion molecule 3 expression'
[patent_app_type] => new
[patent_app_number] => 10/174771
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30494
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232034.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174771 | Antisense modulation of junctional adhesion molecule 3 expression | Jun 16, 2002 | Abandoned |
